T-cell prolymphocytic leukemia epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | {{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and | ==Epidemiology and Demographics== | ||
* T-cell prolymphocytic leukemia is very rare, and it represents 2% of all small lymphocytic leukemias in adults. | |||
* The incidence of T-cell prolymphocytic leukemia increases with age; the median age at diagnosis is 65 years.<ref name="pmid23382603">{{cite journal |vauthors=Graham RL, Cooper B, Krause JR |title=T-cell prolymphocytic leukemia |journal=Proc (Bayl Univ Med Cent) |volume=26 |issue=1 |pages=19–21 |year=2013 |pmid=23382603 |pmc=3523759 |doi= |url=}}</ref> | |||
*Patients with ataxia telangiectasia and T-cell prolymphocytic leukemia are young adults; the median age at diagnosis is 30 years. | |||
*Males are slightly more affected with T-cell prolymphocytic leukemia than females. | |||
*There is no racial predilection for T-cell prolymphocytic leukemia. | |||
T-PLL is a rare leukemia, primarily affecting adults over the age of 30. It represents 2% of all small lymphocytic leukemias in adults.<ref name="mat1">{{cite journal |author=Matutes E, Brito-Babapulle V, Swansbury J, ''et al'' |title=Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia |journal=Blood |volume=78 |issue=12 |pages=3269-74 |year=1991 |pmid=1742486 |doi=}}</ref> | T-PLL is a rare leukemia, primarily affecting adults over the age of 30. It represents 2% of all small lymphocytic leukemias in adults.<ref name="mat1">{{cite journal |author=Matutes E, Brito-Babapulle V, Swansbury J, ''et al'' |title=Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia |journal=Blood |volume=78 |issue=12 |pages=3269-74 |year=1991 |pmid=1742486 |doi=}}</ref> | ||
Revision as of 16:53, 26 March 2019
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia epidemiology and demographics |
|
FDA on T-cell prolymphocytic leukemia epidemiology and demographics |
|
CDC on T-cell prolymphocytic leukemia epidemiology and demographics |
|
T-cell prolymphocytic leukemia epidemiology and demographics in the news |
|
Blogs on T-cell prolymphocytic leukemia epidemiology and demographics |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
Overview
Epidemiology and Demographics
- T-cell prolymphocytic leukemia is very rare, and it represents 2% of all small lymphocytic leukemias in adults.
- The incidence of T-cell prolymphocytic leukemia increases with age; the median age at diagnosis is 65 years.[1]
- Patients with ataxia telangiectasia and T-cell prolymphocytic leukemia are young adults; the median age at diagnosis is 30 years.
- Males are slightly more affected with T-cell prolymphocytic leukemia than females.
- There is no racial predilection for T-cell prolymphocytic leukemia.
T-PLL is a rare leukemia, primarily affecting adults over the age of 30. It represents 2% of all small lymphocytic leukemias in adults.[2]
References
- ↑ Graham RL, Cooper B, Krause JR (2013). "T-cell prolymphocytic leukemia". Proc (Bayl Univ Med Cent). 26 (1): 19–21. PMC 3523759. PMID 23382603.
- ↑ Matutes E, Brito-Babapulle V, Swansbury J; et al. (1991). "Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia". Blood. 78 (12): 3269–74. PMID 1742486.